Skip to main content
PMC home page
Clinical and Experimental Immunology logoLink to Clinical and Experimental Immunology
. 1975 Apr;20(1):155–159.

Increased antibody production following depression of hepatic phagocytosis.

R L Souhami, I E Addison, J W Bradfield
PMCID: PMC1538176  PMID: 1106919

Abstract

The influence of Kupffer cell blockade on the humoral immune response to suboptimal doses of intravenous sheep red blood cells has been measured in mice. Hepatic phagocytosis was suppressed using dextran sulphate. Direct (IgM) and indirect (IgG) plaque-forming cells were measured in spleens from treated and untreated mice at varying times after the antigen. The results show that after Kupffer cell blockade both IgM and IgG responses correspond to the responses seen after a 10-fold greater dose of cells in control animals. The implications of this are discussed.

Full text

PDF
157

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bjorneboe M., Prytz H., Orskov F. Antibodies to intestinal microbes in serum of patients with cirrhosis of the liver. Lancet. 1972 Jan 8;1(7741):58–60. doi: 10.1016/s0140-6736(72)90060-8. [DOI] [PubMed] [Google Scholar]
  2. Bradfield J. W. Control of spillover. The importance of Kupffer-cell function in clinical medicine. Lancet. 1974 Oct 12;2(7885):883–886. doi: 10.1016/s0140-6736(74)91213-6. [DOI] [PubMed] [Google Scholar]
  3. Bradfield J. W., Souhami R. L., Addison I. E. The mechanism of the adjuvant effect of dextran sulphate. Immunology. 1974 Feb;26(2):383–392. [PMC free article] [PubMed] [Google Scholar]
  4. Castell D. O., Johnson R. B. The 198-Au liver scan. An index of portal-systemic collateral circulation in chronic liver disease. N Engl J Med. 1966 Jul 28;275(4):188–192. doi: 10.1056/NEJM196607282750404. [DOI] [PubMed] [Google Scholar]
  5. Eliakim M., Zlotnick A., Slavin S. Gammopathy in liver disease. Prog Liver Dis. 1972;4:403–417. [PubMed] [Google Scholar]
  6. HAVENS W. P., Jr, DICKENSHEETS J., BIERLY J. N., EBERHARD T. P. The half-life of I131 labeled normal human gamma globulin in patients with hepatic cirrhosis. J Immunol. 1954 Oct;73(4):256–258. [PubMed] [Google Scholar]
  7. HAVENS W. P., Jr, SHAFFER J. M., HOPKE C. J., Jr The production of antibody by patients with chronic hepatic disease. J Immunol. 1951 Oct;67(4):347–356. [PubMed] [Google Scholar]
  8. Inchley C. J. The actvity of mouse Kupffer cells following intravenous injection of T4 bacteriophage. Clin Exp Immunol. 1969 Jul;5(1):173–187. [PMC free article] [PubMed] [Google Scholar]
  9. Nossal G. J., Lewis H., Warner N. L. Differential sensitivity of haemolytic plaque methods at various stages of the immune response. Cell Immunol. 1971 Feb;2(1):13–40. doi: 10.1016/0008-8749(71)90023-2. [DOI] [PubMed] [Google Scholar]
  10. Souhami R. L. The effect of colloidal carbon on the organ distribution of sheep red cells and the immune response. Immunology. 1972 Apr;22(4):685–694. [PMC free article] [PubMed] [Google Scholar]
  11. Thomas H. C., McSween R. N., White R. G. Role of the liver in controlling the immunogenicity of commensal bacteria in the gut. Lancet. 1973 Jun 9;1(7815):1288–1291. doi: 10.1016/s0140-6736(73)91300-7. [DOI] [PubMed] [Google Scholar]
  12. Triger D. R., Alp M. H., Wright R. Bacterial and dietary antibodies in liver disease. Lancet. 1972 Jan 8;1(7741):60–63. doi: 10.1016/s0140-6736(72)90061-x. [DOI] [PubMed] [Google Scholar]
  13. Triger D. R., Wright R. Hyperglobulinaemia in liver disease. Lancet. 1973 Jun 30;1(7818):1494–1496. doi: 10.1016/s0140-6736(73)91827-8. [DOI] [PubMed] [Google Scholar]
  14. Wortis H. H., Taylor R. B., Dresser D. W. Antibody production studied by means of the LHG assay. I. The splenic response of CBA mice to sheep erythrocytes. Immunology. 1966 Dec;11(6):603–616. [PMC free article] [PubMed] [Google Scholar]

Articles from Clinical and Experimental Immunology are provided here courtesy of British Society for Immunology

RESOURCES